← Back to Search

Prosthetic Device

Point Partial for Hand Amputation

N/A
Waitlist Available
Research Sponsored by Point Designs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up ~day 60: with prosthesis, 60 days post-fitting
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if the Point Partial prosthetic device helps people with partial finger amputations function better and feel better in everyday life. It aims to show that using this device outside the lab can provide real-world benefits.

Eligible Conditions
  • Hand Amputation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~~day 60: with prosthesis, 60 days post-fitting
This trial's timeline: 3 weeks for screening, Varies for treatment, and ~day 60: with prosthesis, 60 days post-fitting for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Upper Extremity
Disability of the Arm, Shoulder and Hand (DASH)
EuroQol-5 Dimension (EQ-5D-5L)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ProsthesisExperimental Treatment1 Intervention
Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, \~30 days post-fitting, and \~60 days post-fitting
Group II: No ProsthesisActive Control1 Intervention
Baseline outcome measurements will be performed without a prosthesis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point Partial
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Arm DynamicsUNKNOWN
1 Previous Clinical Trials
13 Total Patients Enrolled
Point DesignsLead Sponsor
6 Previous Clinical Trials
55 Total Patients Enrolled
University of Colorado, DenverOTHER
1,798 Previous Clinical Trials
2,797,094 Total Patients Enrolled
~2 spots leftby Oct 2025